Clinical Trials Directory

Trials / Unknown

UnknownNCT06119802

Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation

Status
Unknown
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Yinglong Hou · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

To clarify the predictive effects of uric acid and superoxide dismutase as biomarkers of oxidative stress on atrial fibrillation, and to provide greater value for the diagnosis and prediction of atrial fibrillation. It provides a new idea for the prevention and treatment of atrial fibrillation.

Detailed description

In recent years, a growing number of reports have shown the importance of oxidative stress in the pathophysiological mechanism of AF. During oxidative stress, there is an imbalance between the production of pro-oxidant reactive species and the antioxidant defenses of the cell, and excessive oxidation leads to oxidative damage and cell death. Redox processes can lead to atrial fibrosis and cardiac remodeling , suggesting that strategies to address myocardial oxidative stress may constitute a reasonable approach for the treatment of AF. However, few studies have reported the relationship between comprehensive oxidative stress-related biomarkers and AF. The purpose of this study was to illuminate the relationship of several blood markers of oxidative stress with AF and to provide new clues for the prevention and treatment of AF.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTatrial fibrillationECG of atrial fibrillation last more than 30 seconds.

Timeline

Start date
2022-01-01
Primary completion
2023-10-31
Completion
2024-04-30
First posted
2023-11-07
Last updated
2023-11-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06119802. Inclusion in this directory is not an endorsement.